<DOC>
	<DOCNO>NCT00007059</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine effect bile externalization antibiotic gut sterilization pharmacokinetics mycophenolate mofetil patient undergone orthotopic liver transplantation . II . Correlate serum concentration mycophenolic acid inosine monophosphate dehydrogenase activity patient .</brief_summary>
	<brief_title>Study Pharmacokinetics Mycophenolate Mofetil Patients Who Have Undergone Orthotopic Liver Transplantation</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients begin mycophenolate mofetil ( MMF ) -containing regimen within first 5 day transplantation . Patients blood drawn postoperative day 7 , 21 , 42 , 70 , 98 , 126 , 154 . Urine collect postoperative day 7 , 21 , 42 . Patients T-tube bile externalization also bile collected postoperative day 7 .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Orthotopic liver kidney transplant recipient start mycophenolate mofetilcontaining immunosuppressive regimen within 5 day transplant Kidney transplant recipient serve study control Prior/Concurrent Therapy No concurrent bile acid sequestrants No mycophenolate mofetil part rescue therapy regimen No concurrent albumin replacement therapy Patient Characteristics Renal : Urine output least 500 mL/day OR Creatinine le 2.5 mg/dL Other : Not pregnant No mental incompetency No prisoner parole HIV negative No active infection define : Temperature 101 F WBC great 12,000/mm3 leave shift OR Two positive culture single isolated organism blood , urine , sputum</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>disease-related problem/condition</keyword>
	<keyword>graft versus host disease</keyword>
	<keyword>rare disease</keyword>
</DOC>